• Aucun résultat trouvé

AR222, AR249, AS274, AS702 and AS708 antibodies recognize the spike S protein from SARS-CoV-2 by ELISA

N/A
N/A
Protected

Academic year: 2022

Partager "AR222, AR249, AS274, AS702 and AS708 antibodies recognize the spike S protein from SARS-CoV-2 by ELISA"

Copied!
3
0
0

Texte intégral

(1)

Article

Reference

AR222, AR249, AS274, AS702 and AS708 antibodies recognize the spike S protein from SARS-CoV-2 by ELISA

HAMMEL, Philippe, MARCHETTI, Anna, ZENHAUSERN, Frédéric

Abstract

The recombinant antibodies AI334, AQ806 and RB596 detect by immunofluorescence the spike S protein from SARS-CoV-2.

HAMMEL, Philippe, MARCHETTI, Anna, ZENHAUSERN, Frédéric. AR222, AR249, AS274, AS702 and AS708 antibodies recognize the spike S protein from SARS-CoV-2 by ELISA.

Antibody reports , 2020, vol. 3, no. 4, p. e220

DOI : 10.24450/journals/abrep.2020.e220

Available at:

http://archive-ouverte.unige.ch/unige:155096

Disclaimer: layout of this document may differ from the published version.

1 / 1

(2)

doi:10.24450/journals/abrep.2020.e220 Antibody Reports, 2020, vol. 3, e220

This work is licensed under a Creative Commons Attribution 4.0 International License.

Geneva University Library Open Access Publications https://oap.unige.ch/journals/abrep | ISSN 2624-8557

AR222, AR249, AS274, AS702 and AS708 antibodies recognize the spike S protein from SARS-CoV-2 by ELISA

Philippe Hammel1, Anna Marchetti1, Frederic Zenhausern2,3,4

1 Geneva Antibody Facility, Faculty of Medicine, University of Geneva, 1 rue Michel Servet, CH-1211, Geneva, Switzerland

2 Center for Applied NanoBioscience and Medicine, The University of Arizona, Phoenix, AZ 85004, USA

3 Whitespace Enterprise Corporation, 1305 Auto Drive, Tempe, AZ 85284, USA

4 School of Pharmaceutical Sciences, University of Geneva, 1 rue Michel Servet, CH-1211, Geneva, Switzerland

Abstract

AR222, AR249, AS274, AS702 and AS708 antibodies detect by ELISA the spike S protein from SARS-CoV-2.

Introduction

The spike (S) glycoprotein mediates attachment of coronaviruses to the host ACE2 receptor (through the Receptor-Binding Domain [RBD] in the S1 subunit) and fusion with the host cell membrane (through the S2 subunit) (Yan et al., 2020). Here we describe the ability of five recombinant antibodies (AR222, AR249, AS274, AS702 and AS708) to detect by ELISA the soluble ectodomain of the S protein from SARS-CoV-2 (UniProt P0DTC2).

Materials & Methods

Antibodies: ABCD_AI334, ABCD_AR222, ABCD_AR249, ABCD_AS273, ABCD_AS274, ABCD_AS702 and ABCD_AS708 antibodies (ABCD nomenclature, https://web.expasy.org/abcd/) were produced by the Geneva Antibody Facility (http://www.unige.ch/medecine/antibodies/) as mini- antibodies with the antigen-binding portion fused to a mouse IgG2A Fc. The synthesized scFv sequences (GeneArt, Invitrogen) correspond to the sequences of the variable regions joined by a peptide linker (GGGGS)3 (see Table 1 for clone names and references). HEK293 suspension cells (growing in FreeStyle™ 293 Expression Medium, Gibco #12338) were transiently transfected with the vector coding for the scFv-Fc of each antibody.

Supernatants (see Table 1 for individual yields) were collected after 4 days.

Table 1: Clone number, epitope, reference and production yields for the antibodies used in this study.

ABCD Clone Epitope Reference Yield (mg/L) AI334 CR3022 S1 ter Meulen et al., 2006 50 AR222 Sb#14 S1/RBD Walter et al., 2020 60 AR249 Sb#45 S1/RBD Walter et al., 2020 100 AS273 B38 S1/RBD Wu et al., 2020 <5 AS274 H4 S1/RBD Wu et al., 2020 20 AS702 CV24 S1 Seydoux et al., 2020 20 AS708 CV30 S1/RBD Seydoux et al., 2020 20

Antigen: The prefusion ectodomain (residues 1-1208) of the SARS-CoV-2 S protein, with a KV->PP substitution at residues 986/987, a RRAR->GSAS substitution at residues 682-685, and C-terminal T4 fibritin trimerization motif, protease cleavage site, TwinStrepTag and 8xHisTag (PDB #6VSB; Wrapp et al., 2020), was transiently transfected into 25x108 suspension-adapted ExpiCHO cells (Thermo Fisher) using 1.5 mg plasmid DNA and 7.5 mg of PEI MAX (Polysciences) in 500 mL ProCHO5 medium (Lonza). Incubation with agitation was continued at 31°C and 4.5% CO2 for 5 days. The clarified supernatant was purified in two steps: via a Strep-Tactin XT column (IBA Lifesciences) followed by Superose 6 10/300 GL column (GE Healthcare) to a final concentration of 180 µg/ml in PBS.

Protocol: S protein (10 µg/ml, 50 µl/well in PBS 0.5%

(w/v) BSA, 0.1% (w/v) Tween20) was immobilized on streptavidin-coated ELISA plates (Pierce #15124) for 30 min. Each well was rinsed three times with 100 µl of washing buffer (PBS + 0.5% (w/v) BSA + 0.05% (w/v) Tween20), then incubated for 1 hour with 50 µl of each antibody-containing supernatant diluted in washing buffer (Fig. 1). After rinsing 3 times (100 µl washing buffer), wells were incubated with horseradish peroxidase-coupled goat anti-mouse IgG (Bio-Rad #170-6516, dilution 1:1000, 50 µl per well) for 30 min. After 3 rinses, Tetramethylbenzidine (TMB) substrate (Sigma #T5569) was added (50 µl per well). The reaction was stopped by the addition of 25 µl of 2 M H2SO4. The absorbance (OD) was measured at 450 nm, and the absorbance at 570 nm was subtracted.

Results

We tested by ELISA six antibodies recently developed against the SARS-CoV-2 S protein. From these, five (AR222, AR249, AS274, AS702 and AS708) bound in a concentration-dependent manner to the SARS-CoV-2 S protein (Fig. 1). AI334 was used as a positive control (Hammel et al., 2020); AS273 showed no specific binding, most probably due to the fact that this antibody is poorly produced (Table 1, Fig. 1).

(3)

doi:10.24450/journals/abrep.2020.e220 Antibody Reports, 2020, vol. 3, e220

This work is licensed under a Creative Commons Attribution 4.0 International License.

Geneva University Library Open Access Publications https://oap.unige.ch/journals/abrep | ISSN 2624-8557

References

Hammel P, Marchetti A, Lima WC, et al. AI334 and AQ806 antibodies recognize the spike S protein from SARS-CoV-2 by ELISA. Antib. Rep. 2020; 3:e186.

doi:10.24450/ journals/abrep.2020.e186

Seydoux E, Homad LJ, MacCamy AJ, et al.

Characterization of neutralizing antibodies from a SARS- CoV-2 infected individual. Preprint. bioRxiv 2020;

2020.05.12.091298. PMID:32511342

ter Meulen J, van den Brink EN, Poon LL, et al. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.

PLoS Med. 2006; 3:e237. PMID:16796401

Walter JD, Hutter CAJ, Zimmermann I, et al. Sybodies targeting the SARS-CoV-2 receptor-binding domain.

Preprint. bioRxiv 2020; 2020.04.16.045419.

doi:10.1101/2020.04.16.045419

Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.

Science. 2020; 367:1260-1263. PMID:32075877

Wu Y, Wang F, Shen C, et al. A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science 2020; 368:1274- 1278. PMID:32404477

Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 2020; 367:1444-1448.

PMID:32132184

Acknowledgments

This work was co-sponsored by NASA TRISH contract

#NNX16AO69A/CAT0001. We would like to thank Kelvin Lau, Florence Pojer and Prof. David Hacker (Protein Production and Structure Core Facility, EPFL) for providing the SARS-CoV-2 S protein.

Conflict of interest

The authors declare no conflict of interest.

Fig. 1. Specific binding of AI334, AR222, AR249, AS274, AS702 and AS708 antibodies to the SARS-CoV-2 S protein, as detected by ELISA.

On the Y axis, ELISA signal (in arbitrary units). On the X axis, the antibody dilution (1:100, 1:1’000 and 1:10’000). ‘S refers to the binding to the spike S protein; ‘Ctr’ refers to the binding to biotinylated BSA.

0.0 0.4 0.8 1.2 1.6

0.01 0.001 0.0001

AR249

0.0 0.4 0.8 1.2 1.6

0.01 0.001 0.0001

AS273

0.0 0.4 0.8 1.2 1.6

0.01 0.001 0.0001

AS274

0.0 0.4 0.8 1.2 1.6

0.01 0.001 0.0001

AS702

0.0 0.4 0.8 1.2 1.6

0.01 0.001 0.0001

AI334

Ctr S

0.0 0.4 0.8 1.2 1.6

0.01 0.001 0.0001

AS708 0.0

0.4 0.8 1.2 1.6

0.01 0.001 0.0001

AR222

Références

Documents relatifs

As a negative control, an N-biotinylated peptide corresponding to the last 33 C-terminal residues ( DSGFAAYSRYRIGNYKLNTDHSSSSDNIALLVQ ) of the SARS- CoV-2 M protein

The recombinant antibodies AI334 and AQ806 detect by immunofluorescence the spike S protein from SARS-CoV-2.. MARCHETTI, Anna,

Here we describe the ability of the recombinant antibody RB596 to detect by ELISA the soluble ectodomain of the S protein from SARS-CoV-2 (UniProt P0DTC2).. Materials

Three recombinant antibodies (AI334, AQ806 and RB596) successfully detect by immunofluorescence the S protein from SARS-CoV-2 (UniProt P0DTC2) expressed in Vero- B4

Antibodies MRB155, MRB156 and MRB189 bound in a concentration-dependent manner to the GST-Tsg101 antigen, but not to the GST negative control (Fig. Note that this antigen

The recombinant antibody RB596 recognizes a linear epitope (residues 973-984, ISSVLNDILSRL) from the SARS-CoV-2 spike S protein.. FARRERA SOLER, Lluc,

The recombinant antibodies RB252, RB253, RB254 and RB255 detect by ELISA the human Miner1/CISD2 fused to a GST protein.. HAMMEL, Philippe,

The recombinant antibodies RB501, RB502, RB503, RB504 and RB505 detect by ELISA the human Protein unc-93 homolog B1fused to a GST protein.. WANG, Jennifer Wen-An,